STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
61 hedge funds and large institutions have $88.9M invested in Stemline Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
71% less call options, than puts
Call options by funds: $70K | Put options by funds: $244K
Holders
61
Holding in Top 10
–
Calls
$70K
Puts
$244K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$884K | |
| 3 | +$429K | |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$284K |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$249K |
Top Sellers
| 1 | -$7.27M | |
| 2 | -$2.38M | |
| 3 | -$1.96M | |
| 4 |
QF
QVT Financial
New York
|
-$1.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$483K |